Fujifilm Group - Business Overview

Similar documents
Earnings of FY2018/3 3Q

Innovating out of Crisis

Nomura Investment Forum 2012

About the Fujifilm Group 2. Management Message 16. Message from the CEO 16 Interview with the COO 20. Corporate Governance 24. Business Activities 36

Strategic Capital and Business Alliance Between Fujifilm, Taisho Pharmaceutical and Toyama Chemical

This business company consists of the mainstay office field and the growth field of production print. Office field: KONICA MINOLTA BUSINESS

Outline of the Business Alliance

OPTICS & EM TECHNOLOGIES COMPANY

Fujifilm Growth Strategy with the Acquisition of Wako Pure Chemical Industries

Canon Inc. Third Quarter 2017 Analyst Meeting Tuesday, October 24, 2017

Canon Inc. FY 2018 Analyst Meeting Wednesday, January 30, 2019

Canon Inc. Third Quarter 2018 Analyst Meeting Thursday, October 25, 2018

Konica Minolta Group Medium Term Plan -- Integration Phase -- From April 2004 through March 2007

Blueprint of New Mid term Business plan

Time for Action. Businesses. Basic Policies. The Konica Minolta Group, has formulated and

OTC Virtual Investor Conference

Sony IR Day Imaging Products & Solutions Segment Mobile Communications Segment. May 22, Shigeki Ishizuka

Canon Inc. First Quarter 2018 Analyst Meeting Wednesday, April 25, 2018

Fujifilm s Initiatives in Regenerative Medicine

Business Presentation for Industrial Products

Konica Minolta Group Consolidated Financial Results Fiscal Year ended March 31, May 21, 2004 Konica Minolta Holdings, Inc.

Canon Inc. Speech Summary (English Translation) Executive Vice President & CFO

Financial and Non-Financial Highlights

Details about profit from operating activities and other categories of profit will be provided later in the presentation.

FY2017 to FY2019 Medium-Term Management Plan. March 29, 2017 Shimadzu Corporation President and CEO Teruhisa Ueda

High Performance Plastics (HPP) Company

Today, I will review the progress we made last year and then discuss our initiatives for 2018 onwards.

Newport Corporation. 10 th Annual Needham & Company Growth Conference January 8, 2008

Sales revenue was billion yen, marking a decrease of 2.7 billion yen year-onyear.

Under Phase V of the Excellent Global Corporation Plan a fiveyear initiative started in 2016 we have been working towards reform under the basic

Future Direction of Scientific Solutions & Imaging Business

Company Presentation. May 2010

Welcome to Canon USA. Canon U.S.A., Inc. Business Imaging Solutions Group. One Canon Park Melville, New York

A Shimadzu Brand with a Committed Worldwide Client Base

- Profit attributable to owners of parent increased 700 million yen from a year ago, due largely to a gain on sales of noncurrent assets.

Notice regarding 2 nd Medium-Term Management Plan (FY2019 to FY2021)

Consolidated Financial Results for the Third Quarter Fiscal 2015

In the Midst of Changing Times Revolutionary Technology and Products Driving Corporate Evolution

Creating the Future with Adhesive Technologies. Linkage + Technology LINTEC

Corporate Philosophy and Vision, Brand Mark, Business Management Goals and Other Policies of Mitsubishi Tanabe Pharma Corporation

Investor Overview Presentation ADVANCING LIFE SCIENCE TOGETHER

Three-Year Management Plan 2018 to January 30, 2018 Canon Marketing Japan Inc. Masahiro Sakata, President

PerkinElmer, Inc. JP Morgan Global Healthcare Conference. Robert Friel, Chairman and CEO January 14, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH

Creating the Future with Adhesive Technologies. Linkage + Technology LINTEC

Financial Results for FY2016 and Prospects for FY2017

TO OUR SHAREHOLDERS. Business Results for Fiscal 2001

Results of the 16th MTP. Overview of the 17th MTP.

Konica Minolta to Acquire Invicro (US)

Issues that the Ricoh Group faces

Basic Concept / Targets and Results

Realizing the Future that Regenerative Medicine Will Open

Earning the Confidence of Customers

Copyright NIHON KOHDEN CORPORATION All Rights Reserved

Results by Segment for Fiscal 2017

Company Profile. German-Taiwan Biotech Seminar 6 November 2017

Completing the Kodak Transformation

In terms of the analysis of operating income, operating income has fallen and the deterioration of the gross profit in Q1 has had a negative impact

Creating Corporate Value

Agfa-Gevaert. May 2004

Capital Market Day June 12, 2012

6 th Mid-Term Business Plan

Konica Minolta's Journey So Far Net sales / Revenue (Billions of yen)

BEYOND 300 (FY FY2020)

Company Overview and Characteristics

1

NEWS RELEASE SHOWA DENKO K.K. 13-9, Shiba Daimon 1-chome Minato-ku, Tokyo

PVC/Chlor-Alkali Business

OPPORTUNITIES FOR CHEMICALS AND MATERIALS IN PV

Results Presentation Fiscal 2016 First Quarter

Creating, Saving and Storing. Fast, Fine and Beautiful. Telecommunications. Environment & Energy. Main Products Circuit Connecting Films for Displays

Delivering total print solutions

Disclosure of FY2015 financial results

33.8% Revenue Breakdown by Business Segment. Elastomers 51.6% Plastics 14.6% Petrochemical Products Business JSR CORPORATION ANNUAL REPORT 2014

Operating Results and Financial Position FY2006 Results & FY2007 Outlook

FUJIFILM Holdings to own 50.1% of Xerox Corporation s shares, and the combination of Fuji Xerox and Xerox Corporation

Investor Presentation Parade to Acquire Cypress s TrueTouch Mobile Business

Yakult Vision 2020 Phase III Plan ( )

VISION & STRATEGY FIC LIC. Interview with the President

FY2004 Highlights. April 21, Motoki Ozaki President and CEO Kao Corporation

Beyond the Horizon (FY ) New Medium-Term Business Plan. - 1st Stage of Growth Strategy Toward Attaining the Corporate Vision - Masayuki Sato

Completing the Kodak Transformation

Overview of Radiation Curing Market and Technologies in Japan. Teruo Orikasa RadTech Japan RadTech North America 2012

Basic Concept/Targets and Results

Net sales of the Konica Minolta Group for the fiscal year ended March 31, 2011, declined 26.5 billion, or 3%, year on year, and operating income fell

Investor Presentation

Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q

Progress Report. Jouko Karvinen CEO of Medical Systems

TANAKA Confirms Improvement in Bending Durability of Flexible Touch Panels With Single-Sided, Dual-Layer Wiring Structure Metal Mesh Film

1Q14 QUARTERLY EARNINGS

Investor Presentation. November 2016

AGC Inc. Minutes of Briefings on Operating Results for 2Q FY2018

Sales decreased despite increased sales in business solutions, which were offset by decreased sales in other segments.

This presentation contains consolidated financial results for the first quarter of the fiscal year 2017, ending March 31, 2017.

Business Results for the Fiscal Year Ended September 30, 2011

Corporate Strategy Meeting For the Fiscal Year ending March 31, 2014

Midterm Management Plan

Highlights for the 1 st Half of FY2010

Emerging onto a Still Wider Stage

Management Direction. FY2018 Progress Review. October 26, 2018 Fujitsu Limited. Copyright 2018 FUJITSU LIMITED

Your ideas. Our technologies.

Transcription:

Fujifilm Group - Business Overview Nov. 2017 FORWARD-LOOKING STATEMENTS Forward-looking statements, such as those relating to earnings forecasts and other projections contained in this material, are management s current assumptions and beliefs based on currently available information. Such forward-looking statements are subject to a number of risks, uncertainties, and other factors. Accordingly, actual results may differ materially from those projected due to various factors. 1. Business Fields of Fujifilm Group Production services 13% Office printers Office products Others 11% Global services 15% Document Solutions 1,080.9 billion (46%) 44% 17% Photo imaging 69% Imaging FY2017/3 Revenue 2,322.2 billion Optical Device & Electronic Imaging products 31% Solutions 341.8 billion (15%) Graphic systems 29% Information Solutions 899.5 billion (39%) 5% 12% Healthcare 11% 43% Display materials Industrial products and Electronic materials Recording media Highly functional materials 2

2. Wave of Digitalization and Management Reform 100 Demand for photographic film dropped rapidly after its peak in 2000 due to digitalization *Index based on an aggregate demand of 100 in FY2001/3 Core technologies created from its photographic business Making film bases Expanding and uniformly flattening molten materials in units of micrometers to make an optically warp-free, thin film 80 Rapid Decline Making photosensitive emulsions 60 40 20 0 FY1994/3 Peak FY2001/3 FY2011/3 Coating functional materials on base films About 20μm Designing functional materials at the nanometer level High-speed simultaneous coating of multiple uniform layers Boldly diversified its business utilizing its high technological capabilities cultivated through photographic business Section of color film (after development) Photographing with a camera Ensuring the high-quality design and manufacture of lenses, hardware, and systems Developing and printing photographs Controlling chemical reactions to ensure proper images and building appropriate systems 3 2. Wave of Digitalization and Management Reform Developing wide-range of businesses utilizing core technologies cultivated through its photographic business Concentrated management resources into the selected six priority business fields Capital Investment R&D M&A Investment 4

3. Priority business fields Business Portfolio Healthcare Consists of medical systems, pharmaceuticals, Bio-CDMO, regenerative medicine and life sciences (cosmetics). Realize stable profit growth in medical systems. Aim to launch new drugs around 2018 Three fields that drive growth among priority business fields Highly Functional Materials Consists of display materials, industrial products & electronics materials and fine chemical. Maintain stable profit in display materials. Create a number of new businesses with high profitability in highly functional materials fields Support growth by stable profit base Large-scale businesses such as Graphic systems and Photo imaging Document A Fuji Xerox business that offers multifunction devices, printers, and solution services Strengthen device sales in emerging countries and promote solution services in developed countries 5 4. Imaging Solutions Photo Imaging Revenue in FY2017/3 236.8 billion Main products are photographic paper (color paper) and the instax instant camera Color paper Instax instant camera Expand business by reinforcing sales of such high-value-added printing services as Photobook Sales are expanding worldwide triggered by the boom in sales in Asia. Unit sales are breaking records. Year Album Optimized business structure to meet the decline in demand for photographic film and created a structure that can generate stable profit 6

4. Imaging Solutions Optical Device & Electronic Imaging Products Revenue in FY2017/3 105.0 billion Digital Cameras Cinema lenses Optical Device & Electronic Imaging Utilizing the synergies between Optical Device and Electronic Imaging business Expand sales by appealing FUJINON brand s advanced lens technologies and imaging technologies. Strengthen sales of the products such as high-end digital cameras, surveillance lenses, where the market growth is expected 7 4. Imaging Solutions Optical Device & Electronic Imaging (Digital camera) Focus on high-end models X Series and differentiated products Realize high image quality that surpasses single-lens reflex cameras by premium mirrorless cameras X Series (premium compact cameras) X Series (mirrorless cameras) Medium format mirrorless camera, adopting a large sized sensor Differentiated products (water-proof, long-zoom) Focus on high-end models, mainly X Series and interchangeable lenses 8

Healthcare Revenue in FY2017/3 384.0 billion Medical Systems: Diagnosis X-ray diagnostic imaging systems (FCR/DR/film) Endoscopes Medical-use picture archiving and communications systems (PACS) Ultrasound IVD Functional cosmetics Life Sciences : Prevention Pharmaceuticals : Treatment Pharmaceuticals Bio-CDMO : Treatment Regenerative Medicine : Treatment Supplements Bio pharmaceuticals Autologous Cultured epidermis Autologous Cultured cartilage Generate stable profit in medical systems Launch unique new drugs in pharmaceuticals in the medium term 9 Healthcare (Medical Systems) X-ray Imaging Diagnostic Equipment Services Endoscopes Ultrasound Medical IT In Vitro Diagnosis Growth fields are medical-use picture archiving and communications systems (medical IT), endoscopes, ultrasound, and In Vitro Diagnosis. - Improve cost competitiveness by cost reduction and minimizing fixed costs in equipment - Increase market share for materials, making it a cash cow business - Strengthen sales in emerging countries 10

Healthcare (Medical Systems) Medical IT SYNAPSE medical-use picture archiving and communications systems (PACS) attain the No.1 share in Japan. Gain a position as owner of big data by utilizing advantage of open platform. Provide various applications, which support image diagnosis by analyzing accumulated data. CT/MRI Ultrasound equipment Patient information Medical IT systems to integrate images and information at hospitals Electronic medical records IVD Endoscopes Data accumulated in systems of Fujifilm is expanding Regional Partnership Other hospitals and clinics in regions X ray imaging diagnostic equipment 3D image analysis system SYNAPSE VINCENT Realize business growth by responding to market demand for efficiency in medical treatment 11 Healthcare (Medical Systems) Endoscopes Launch differentiated products with high value-added, that utilizes image processing technology cultivated through the photographic business and thinner sizing technology etc. - Transnasal endoscopes - Endoscope systems with laser light sources - Double-balloon endoscopes Transnasal Endoscopes Transnasal endoscope Former endoscope Lessen the patient s discomfort by streamlining superfine transnasal endoscope Surface of mucous membrane Mucous membrane Two types of laser light source Blood vessel Image processing technology Endoscope system with laser light sources By fusing Fujifilm s image processing technology, the visibility of the diseased part improved. Realize sales growth by expanding sales of differentiated products 12

Healthcare (Medical Systems) Ultrasound In March 2012, Fujifilm acquired SonoSite, the U.S.-based leading manufacturer of bedside and point-of-care (POC) ultrasound diagnostic equipment. 2014 High image processing technology Sales network in Asia Strong in diagnosis market Group Synergies Rich knowhow/knowledge Over half of its sales in North America Strong in POC market 2011 650.0 billion Portable 110.0 billion Ultrasound 740.0 billion Portable 140.0 billion Further growth IHS 2014 Develop new products utilizing group synergies Strengthen sales utilizing sales channels of both companies Sonosite iviz, A tablet type ultrasound diagnostic equipment Aim to achieve top share in portable ultrasound diagnostic equipment market, where high growth is expected 13 Healthcare (Medical Systems) X-ray film Global demand is gradually declining and Fujifilm is focusing on increasing its market share. In emerging countries, demand for film used for output proceeds steadily. X-ray diagnostic imaging systems FCR: Fuji Computed Radiography. Fujifilm was the first to develop this medical equipment (launched in 1983) and has a high market share. There are only four manufacturers of CR equipment in the world. DR: Digital Radiography. Several manufacturers are entering this field and competition is intensifying. Accumulate image information Digitization Check on PC monitor Imaging plate (IP) IP cassettes X-ray exposure Read the film Film output Realized significant X-ray diagnostic imaging system cost reductions of by reviewing its equipment design and parts procurement costs. Improved profitability. 14

Healthcare (Pharmaceuticals) Built a business foundation via M&A of business firms Conduct sales of existing drugs from consolidated subsidiaries, mainly from Toyama Chemical, and R&D for new drugs Business foundation by group companies Low-molecular drugs Toyama Chemical A top-class pharmaceuticals company for infectious disease medicines in Japan Conduct development and manufacture FUJIFILM Pharma Sales company that offers brand-name drugs and generics FUJIFILM Finechemicals Manufacture of raw materials Biopharmaceuticals FUJIFILM RI Pharma One of two specialty pharmaceutical companies in Japan that develops, manufactures, and markets radiopharmaceuticals and medicines FUJIFILM Diosynth Biotechnologies A contract Development & manufacturing organization (CDMO) for biopharmaceuticals and manufacturing base. Fujifilm R&D Pharmaceuticals & Healthcare Research Laboratories Conducts R&D of new drugs, using Fujifilm s core technologies 15 Healthcare (Pharmaceuticals) Development code Therapeutic category Formulation Region Development stage T-705 Anti-influenza drug Oral Japan U.S.A. Approved PⅢ T-3811 Quinolone synthetic antibacterial drug Oral China Submitted an application for permission T-2307 Antifungal drug Injection U.S.A. PⅠ completed T-817MA Alzheimer's disease drug Oral U.S.A. Japan PⅡ completed PⅡ completed T-4288 New fluoroketolide antibacterial drug Oral Japan PⅢ ITK-1 Bio Castration-resistant prostate cancer drug Injection Japan PⅢ FF-10501 Relapsed or Refractory myelodysplastic syndrome drug Oral FF-10502 FF-21101 Bio Advanced/recurrent pancreatic/ovarian cancer drug Advanced/recurrent solid cancer drug (armed antibody) Injecti on Injection Japan U.S.A. U.S.A. Europe /Japan U.S.A. Japan PⅠ completed PⅡ PⅠ Preparing for PⅠ PⅠ Preparing for PⅠ F-1311 Diagnostic drug for prostate cancer (Radiopharmaceuticals) Injectiom Japan PⅡcompleted FF-10101 Acute Myeloid Leukemia (AML) drug Oral U.S.A. PⅠ F-1515 neuroendocrine carcinoma drug (Radiopharmaceuticals) injection Japan PⅠ FF-10102 Autoimmune disease drug Oral U.S.A. Europe /Japan Non clinical trial FF-10832 Advanced solid cancer drug (Gemcitabine liposome) Injection U.S.A. Non clinical trial Note: FKB327 (a biosimilar of adalimumab) of FUJIFILM KYOWA KIRIN Biologics (FKB), an equity method affiliated company, is filed in EU. FKB238 (a biosimilar of bevacizumab ) of JV between FKB and AstraZeneca is under phase Ⅲclinical trial in U.S.A., Europe, and others. 16

Healthcare (Regenerative Medicine) The Three Key Components for Regenerative Medicine Cell Scaffold (recombinant peptide) Cell Culture Medium/ Cytokine Contributing to the elevation of regenerative medicine business to the industrial stage while leveraging synergies between the three companies. Expansion of drugs discovery support business that utilize ips cells Commercialization of cell therapy (Age-related macular degeneration, Parkinson s disease, heart failure, etc.) 17 Healthcare (Life Sciences) Utilizing technologies cultivated through its photographic business, Fujifilm started its cosmetics business in 2006. Fujifilm expanded its lineups, such as the ASTALIFT series, the Lunamer series with women in their 20s and 30s as its main target. The ASTALIFT series is a total healthcare brand that includes base makeup, supplements, and hair care products in addition to skincare products. ASTALIFT series Lunamer series Supplement Differentiate itself from competitors and offer its original products supported by science, utilizing proprietary technologies 18

Healthcare (Life Sciences) Link between photographic technologies and cosmetics The major component of photo film is collagen, the same as that of the skin The antioxidant technology of photo film is used Without antioxidant technology The nano-technology for photographic exposure and color development is used Conventional Nano-technology New Nano-technology Collagen Collagen Main ingredient of photo film Forms about 70% of dermis 25 years after With antioxidant technology Oxidation Causes color fading of photos Causes skin blemishes and aging Nano-technology Used for exposure and color development of photos Improves permeability and absorption of ingredients 19 Highly Functional Materials (Display Materials) Our functional materials which are used in LCDs Front Protective film for polarizer Polarizer Compensation film Glass ガラス基板 Substrate Color Filter LCD Cell TFT Polarizer PVA (stretched PVA doped with iodine) Liquid Crystal Layer Glass Substrate Compensation film PVA Protective film for polarizer Revenue in FY2017/3 97.8 billion Our Products FUJITAC WV/VA/IPS film Transer Film Color filter transferred on to the glass substrate WV/VA/IPS film FUJITAC Back Light Differences in LCD modes TN mode VA mode IPS mode Contrast Viewing angle (Using WV film) (Using retardation film) (Using Z-TAC) Efficiency of light emission Manufacturing cost Low Middle High To cover weak points or improve quality, compensation films are used 20

Highly Functional Materials (Display Materials) FUJITAC WV film VA film IPS film (Z-TAC) Protective film for polarizer. Used regardless of any difference in LCD mode. A compensation film that widens the viewing angle in TN mode. Fujifilm has 100% market share. A film used for the polarizer in VA mode to control the inflection of light for better viewing angles and contrast. A film used for the polarizer in IPS mode to contain tint fluctuations when the screen is viewed diagonally. Diagram showing volume of panel shipments and main films used by application small & mid-sized display NoteBook PC Monitor TV FUJITAC WV (TN) VA Z-TAC (IPS) TVs Monitors Partly used Notebook PCs Partly used Partly used Small and medium-sized displays Partly used (tablet PCs/smartphones) (as of Jan.-Dec.201, internal investigation) 21 Highly Functional Materials (Display Materials) For TVs Screens for LCD panels continues to expand owing to such factors as the increase in the size of TVs Promote sales of VA/IPS film and FUJITAC Introduced low-shrinkage Z-TAC to meet the needs of low moisture permeability for IPS mode For small and medium-sized displays Reinforce sales of super-thin 25μm FUJITAC and Z-TAC for smartphones, where the demand is expected to grow, and for tablet PC Depreciation costs have been reduced as large capital investments have almost run their course. Maintain high profitability as a cash cow business 22

Highly Functional Materials (Industrial Products, Electronics Materials & Fine Chemical) Revenue in FY2017/3 111.1 billion Industrial Products Existing business Non-destructive testing equipment and materials (Industrial-use X-ray films, digital X-ray imaging system) Microfilters PRESCALE (pressure measurement film) New business <EXCLEAR> Sensor film for touch panels Realize high transparency and flexibility by patterning with silver on a transparent PET base film. Low resistance and can be adjusted to mediumto large-sized touch panels. Enables simplified manufacturing process. <Backsheets for solar cells> Have a role in protecting the reverse side of outdoor solar cells from rain, UV, and other damaging elements. Three times more durable than general PET, and have acquired certification in a module base Continuously create new high-value-added businesses/products that can utilize Fujifilm s technologies and have high profitability, mainly in the growth fields of touch panels and environment/energy 23 Highly Functional Materials (Industrial Products, Electronics Materials & Fine Chemical) Electronics Materials Offer products used when manufacturing semiconductors IC chip Cross section Wirings are bonded within the multi-layer structure G R B G Image sensor consists of red (R), green (G), and blue (B) Wiring Image sensor Photoresist CMP slurry Color resist A material indispensable for manufacturing ultra-small circuit patterns on semiconductors. It is used during the process where the circuit pattern is printed onto a wafer. An abrasive material used to precisely planarize substrate that has various materials in its circuit structure, like metal or dielectrics A photo-sensitive coloring material for manufacturing micro color filters, used in image sensors. Expand sales by offering leading-edge products, leveraging Fujifilm s wide-ranging product portfolio and stable supply capabilities 24

Highly Functional Materials (Industrial Products, Electronics Materials & Fine Chemical) Fine Chemical Expand its business of high-function chemicals and laboratory chemicals. Laboratory Chemicals Use in R&D for new drugs and other cutting-edge technologies and products, as well as in environmental analysis on water and soil quality. Expanding sales by utilizing its product development and manufacturing system to match small quantity of diversified products needs and a sales network that covers all of Japan. High-function chemicals Utilize chemical synthesis technology cultivated from laboratory chemicals manufacturing to develop competitive products including Azo polymerization initiator necessary to manufacture superabsorbent polymer used in disposable diaper and others. Launched the Fine Chemical Division as of April, 2017 Reinforcing the business structure for synergy with Wako Pure Chemical Industries 25 Recording Media Revenue in FY2017/3 47.6 billion Since Fujifilm developed professional-use videotapes in 1959, the Company has offered products with high performance and high reliability to tape drive manufacturers throughout the world. Magnetic tapes for data storage Fujifilm s magnetic tapes for data storage with barium ferrite particles (BaFe), which were developed by Fujifilm s proprietary technologies, are achieving a high reputation in the market. Large capacity Long archival life Highly cost effectiveness Recording stability Energy-saving Professional-use videotapes Mainly used by broadcasting stations Further usage in the data archive field is expected, reflecting the rapid increase of data in the world and the popularization of cloud computing. New data archiving service dternity Reinforce sales promotion, leveraging original BaFe products 26

Graphic Systems/ Inkjet Revenue in FY2017/3 255.8 billion Offset printing materials and equipments Graphic arts films Printing plates (conventional plates,ctp (Computer to Plate) plates) Inkjet digital presses JetPress series Wide-format inkjet systems Inkjet heads and inks for industrial-use printers High productivity Suitable for large volume printing such as newspapers and publications Mainstream is usage of CTP plate, which directly exposes printing data made by computer to printing plate On-demand printing suitable for small print runs. Expect future growth by diversification of market needs Suitable for commercial printing such as package printing Inkjet heads and inks for industrial-use printers for various purposes as construction materials. Focusing on the growth market of inkjet digital presses and inkjet heads for industrial-use printers while securing stable profit with CTP plates 27 6. Document Solutions Document Revenue in FY2017/3 1,080.9 billion Document solutions is a business conducted by Fuji Xerox. FUJIFILM Holdings has a 75% share of the stock, and the rest is held by Xerox Corporation. Products that Fuji Xerox develops and manufactures are also exported to Xerox Corporation. Through Xerox Corporation, Fuji Xerox offers products globally. Business is operated in cooperation with U.S.-based Xerox Corporation 28

6. Document Solutions Document Asia (China) Japan/Oceania Large enterprises, A region where Fuji Xerox is strong Government administration offices Cover by long experience of direct sales Medium-tosmall scale enterprises Prepare/strengthen dealer networks and aggressively reach the mass retailer market Accelerate mass sales of low-end models that meet local needs to acquire substantial market share DocuCentre S2110 Offer solution services that support and resolve management as well as operational issues, which are becoming more diversified and complex, from a document viewpoint Continuous measures to reduce costs Expand customer bases in Asia, mainly China, and reinforce solution services in such developed countries as Japan and Oceania by utilizing Fuji Xerox s long experience of direct sales Increase profitability by continuous cost reductions 29 6. Document Solutions Document Office products & printers Office products Offer multifunction devices and consumables for offices. Offer a wide range of solution services for document management and mission-critical operations through software that realizes interoperabilty of multifunction devices with various types of operational systems and applications. Office printers Offer small, highly functional, and high image quality color and monochrome laser printers in Japan and the Asia-Oceania region as well as in the European and U.S. markets through OEM supply. 30

6. Document Solutions Document Production Services Offer on-demand printing systems for the digital printing market and continuous feed printers for clients mission-critical operations. Offer services that will support operating workflows and marketing communications Solutions & Services Conclude contracts for the continuous optimization of document-related operating processes or whole value chains, which include the pre and post-procedures of the operating process. Contracts to include services that support the optimization of clients overall print environments (Managed Print Service: MPS). Expand business in the Asia-Oceania region by maximizing synergies with an Australian service provider acquired in FY2013/3. 31 Appendix Investor Relations Website FUJIFILM Holdings - Investor Relations http://www.fujifilmholdings.com/en/investors/index.html Earnings Presentations http://www.fujifilmholdings.com/en/investors/ir_events/earnings_presentations/index.html Earnings presentation materials (transcript attached), main responses to queries, and more IR Events Materials http://www.fujifilmholdings.com/en/investors/ir_events/business_presentations/index.html Conference materials, business presentation materials, and more What Kind of Company is Fujifilm? http://www.fujifilmholdings.com/en/investors/guidance/index.html 32